Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study

NCT04917731 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04917731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04917731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
June 2, 2021
Completion date
June 2, 2023
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cold intolerance